KR100543560B1 - 피하 또는 피부내 주사용 삽입물 - Google Patents
피하 또는 피부내 주사용 삽입물 Download PDFInfo
- Publication number
- KR100543560B1 KR100543560B1 KR1019997001267A KR19997001267A KR100543560B1 KR 100543560 B1 KR100543560 B1 KR 100543560B1 KR 1019997001267 A KR1019997001267 A KR 1019997001267A KR 19997001267 A KR19997001267 A KR 19997001267A KR 100543560 B1 KR100543560 B1 KR 100543560B1
- Authority
- KR
- South Korea
- Prior art keywords
- microspheres
- vial
- insert
- particulates
- injectable
- Prior art date
Links
- 238000007920 subcutaneous administration Methods 0.000 title claims abstract description 8
- 238000002347 injection Methods 0.000 title description 9
- 239000007924 injection Substances 0.000 title description 9
- 239000007943 implant Substances 0.000 title description 2
- 239000004005 microsphere Substances 0.000 claims abstract description 38
- 239000000725 suspension Substances 0.000 claims abstract description 10
- 229920000642 polymer Polymers 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 15
- 239000004626 polylactic acid Substances 0.000 claims description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000010419 fine particle Substances 0.000 claims description 6
- 239000008215 water for injection Substances 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- 229910001873 dinitrogen Inorganic materials 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000003349 gelling agent Substances 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 claims description 2
- 239000003708 ampul Substances 0.000 claims description 2
- 239000012298 atmosphere Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229940022769 d- lactic acid Drugs 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- 230000001698 pyrogenic effect Effects 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000001132 ultrasonic dispersion Methods 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims 2
- 230000008014 freezing Effects 0.000 claims 2
- 230000001678 irradiating effect Effects 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 230000005251 gamma ray Effects 0.000 claims 1
- 230000001172 regenerating effect Effects 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 4
- 238000002316 cosmetic surgery Methods 0.000 abstract description 3
- 238000011282 treatment Methods 0.000 abstract description 3
- 208000032544 Cicatrix Diseases 0.000 abstract description 2
- 230000002688 persistence Effects 0.000 abstract description 2
- 231100000241 scar Toxicity 0.000 abstract description 2
- 230000037387 scars Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 16
- 239000000499 gel Substances 0.000 description 15
- 239000002245 particle Substances 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 6
- 229920000053 polysorbate 80 Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229940117828 polylactic acid-polyglycolic acid copolymer Drugs 0.000 description 5
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- -1 polytetrafluoroethylene Polymers 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 229920001610 polycaprolactone Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000003903 lactic acid esters Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/025—Explicitly spheroidal or spherical shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0059—Cosmetic or alloplastic implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims (15)
- 생체 흡수가능하며, 락트산 폴리머, 글리콜산 폴리머 및 락트산-글리콜산 공중합체로 이루어진 군으로부터 선택된 1종 이상의 폴리머를 포함하는 미소구체 또는 미립자의 겔 현탁액을 포함하며, 상기 미소구체(microsphere) 또는 미립자의 평균 직경이 5∼150㎛인, 사람에게 투여할 수 있는 피하 또는 피부내 주사형 삽입물.
- 삭제
- 제1항에 있어서, 겔 중의 미소구체 또는 미립자 함유율이 50∼300g/ℓ인 것을 특징으로 하는 삽입물.
- 제1항에 있어서, 상기 미소구체 또는 미립자의 평균 직경이 20∼80㎛인 것을 특징으로 하는 삽입물.
- 제1항에 있어서, 상기 미소구체 또는 미립자가 1∼3년 이내에 생체 흡수가능한 것임을 특징으로 하는 삽입물.
- 제1항에 있어서, 상기 폴리머가 폴리-L-락트산, 폴리-D-락트산 및 그의 혼합물로 이루어진 군으로부터 선택된 폴리락트산인 것을 특징으로 하는 삽입물.
- 제6항에 있어서, 상기 폴리락트산이 분자량이 70,000∼175,000달톤이고, 고유 점도가 3∼4㎗/g이며, 모노머 잔류율이 0.1% 미만이고, 용매 잔류율이 0.01% 미만인 것을 특징으로 하는 삽입물.
- 제1항에 있어서, 상기 겔이 주성분으로서 겔화제인 카르복시메틸셀룰로오즈 (CMC) 또는 하이드록시프로필메틸셀룰로오즈(HPMC)를 포함하고 그의 함량이 0.1∼7.5중량%인 것을 특징으로 하는 삽입물.
- 제1항, 3항 내지 8항중 어느 한항에 따른 주사형 삽입물을 동결 건조시켜 제조하며 주사용 물을 가하면 피하 또는 피부내에 주사가능한 주사용 삽입물로 재생성될 수 있는 동결건조제품.
- 제1항, 3항 내지 8항중 어느 한항에 따른 주사형 삽입물이 미리 채워져 있는, 바늘이 구비된 멸균 주사기.
- 제1항, 3항 내지 8항중 어느 한항에 따른 주사형 삽입물을 포함하는 멸균 현탁액의 바이알.
- 주사용 물이 들어있는 앰플과 함께 제공되는, 제9항에 따른 동결 건조 생성물을 포함하는 바이알.
- 두칸으로 분리되어 있으며 그중 한칸에는 제9항에 따른 동결 건조 생성물이, 다른 칸에는 주사용 물이 미리 채워져 있는 주사기.
- 삭제
- - -80℃ 이하의 온도에서, 0.22㎛로 여과된 질소 가스 하에서 폴리머를 100㎛ 스크리닝 그리드 상에서 냉각분쇄 (cryogrinding)하는 단계;- 미립자를 100㎛ 스테인레스강 그리드 상에서 시이빙하는 단계;- 교반하에, 카르복시메틸셀룰로오즈, 비발열성 만니톨 및 폴리소르베이트를 주사용 물에 용해시켜 제조한 용액을 포함하는 동결건조 매질을 제조하고 이렇게 얻어진 용액을 0.22㎛에서 여과된 질소 가스 분위기하에서 0.22㎛에서 여과한 다음 오오토클레이브에 넣어 121.5℃에서 20분 동안 멸균하는 단계;- 4㎖ 공칭 용량의 바이알 한 개당 100㎎의 비율로 미립자를 분배하는 단계;- 동결 건조 매질을 폴리머 미립자가 이미 들어있는 바이알에 1.05±0.05g의 비율로 분배하는 단계;- 균일한 현탁액을 얻기 위해 초음파 분산 시스템을 이용하여 미립자를 동결 건조 매질에 분산시키는 단계;- 기둥형 마개를 이용하여 바이알을 미리 닫고 -70℃ 이하로 급속 냉동시킨 다음, 냉동된 바이알을 -40℃ 아래에서 저장하고, 마지막으로 바이알을 동결 건조하고 자동으로 마개를 닫는 단계; 및- 캡슐을 만들고 바이알을 조사한 다음 γ선을 조사하여 멸균하는 단계를 포함하는, 제1항, 제3항 내지 8항중 어느 한항에 따른 삽입물을 동결 건조된 폴리머 미립자 형태로 제조하는 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9707334A FR2764514B1 (fr) | 1997-06-13 | 1997-06-13 | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
FR97/07334 | 1997-06-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000068167A KR20000068167A (ko) | 2000-11-25 |
KR100543560B1 true KR100543560B1 (ko) | 2006-01-20 |
Family
ID=9507929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019997001267A KR100543560B1 (ko) | 1997-06-13 | 1998-06-12 | 피하 또는 피부내 주사용 삽입물 |
Country Status (21)
Country | Link |
---|---|
US (4) | US6716251B1 (ko) |
EP (1) | EP0969883B1 (ko) |
JP (1) | JP2000516839A (ko) |
KR (1) | KR100543560B1 (ko) |
AT (1) | ATE253947T1 (ko) |
AU (1) | AU744366B2 (ko) |
BR (1) | BR9804962A (ko) |
CA (1) | CA2263361C (ko) |
DE (1) | DE69819694T2 (ko) |
DK (1) | DK0969883T3 (ko) |
ES (1) | ES2210776T3 (ko) |
FR (1) | FR2764514B1 (ko) |
HK (1) | HK1025268A1 (ko) |
HU (1) | HU228462B1 (ko) |
IL (1) | IL128210A (ko) |
PL (1) | PL331703A1 (ko) |
PT (1) | PT969883E (ko) |
RO (1) | RO118261B1 (ko) |
RU (1) | RU2214283C2 (ko) |
TR (1) | TR199900297T1 (ko) |
WO (1) | WO1998056431A1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100759091B1 (ko) | 2006-12-13 | 2007-09-17 | 조강선 | 피부 충전제 조성물 |
KR101852127B1 (ko) | 2016-04-11 | 2018-04-25 | 주식회사 지씨에스 | 폴리엘락틱산 필러와 히알루론산 필러 결합체의 제조방법 |
WO2020184744A1 (ko) * | 2019-03-08 | 2020-09-17 | 주식회사 지씨에스 | 복합체의 제조 방법 |
Families Citing this family (125)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2764514B1 (fr) * | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
FR2778847A1 (fr) * | 1998-05-20 | 1999-11-26 | Jean Pierre Perraud | Implant injectable en sous gingival resorbable, constitue de microspheres a liberation prolongee et chargees en principes actifs et en suspension dans un gel vecteur |
CA2383054C (en) * | 1999-09-14 | 2009-12-08 | Tepha, Inc. | Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation |
US6423332B1 (en) | 2000-05-26 | 2002-07-23 | Ethicon, Inc. | Method and composition for deforming soft tissues |
DE10026620A1 (de) * | 2000-05-29 | 2002-03-07 | Gerhard Quelle | Poröse Implantate und Partikel |
US7666588B2 (en) * | 2001-03-02 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
MXPA03010679A (es) * | 2001-05-23 | 2004-03-02 | Tanabe Seiyaku Co | Una composicion para acelerar la cicatrizacion de fractura osea. |
KR20040007583A (ko) * | 2001-05-23 | 2004-01-24 | 다나베 세이야꾸 가부시키가이샤 | 연골 질환의 재생치료용 조성물 |
CA2452412C (en) | 2001-06-29 | 2011-05-24 | Medgraft Microtech, Inc. | Biodegradable injectable implants and related methods of manufacture and use |
US7419949B2 (en) * | 2001-07-16 | 2008-09-02 | Novo Noridsk Healthcare A/G | Single-dose administration of factor VIIa |
US20040054414A1 (en) | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
US7744651B2 (en) * | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
CN100394989C (zh) * | 2002-11-15 | 2008-06-18 | 华沙整形外科股份有限公司 | 包含微粒状基于胶原材料的组合物的制药应用和包含所述组合物的滑膜关节 |
US20040186471A1 (en) * | 2002-12-07 | 2004-09-23 | Sdgi Holdings, Inc. | Method and apparatus for intervertebral disc expansion |
US7965719B2 (en) * | 2002-12-11 | 2011-06-21 | Broadcom Corporation | Media exchange network supporting multiple broadband network and service provider infrastructures |
FR2850282B1 (fr) * | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
EP1454630B1 (en) * | 2003-03-04 | 2010-10-20 | The Technology Development Company Ltd. | Long acting injectable insulin composition and methods of making and using thereof |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US7754233B2 (en) * | 2004-09-03 | 2010-07-13 | Ethicon, Inc. | Method of preventing post-operative surgical adhesion |
US8440215B2 (en) | 2004-09-03 | 2013-05-14 | Ethicon, Inc. | Absorbable polymer formulations |
US7244270B2 (en) * | 2004-09-16 | 2007-07-17 | Evera Medical | Systems and devices for soft tissue augmentation |
US20060058891A1 (en) * | 2004-09-16 | 2006-03-16 | Lesh Michael D | Transformable tissue bulking device |
US7641688B2 (en) * | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
WO2006034077A1 (en) * | 2004-09-16 | 2006-03-30 | Juva Medical, Inc. | Tissue augmentation device |
ITPD20040312A1 (it) * | 2004-12-15 | 2005-03-15 | Fidia Advanced Biopolymers Srl | Protesi e o supporto per la sostituzione, riparazione, rigenerazione del menisco |
US9205047B2 (en) * | 2005-04-25 | 2015-12-08 | The Governing Council Of The University Of Toronto | Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix |
US7767656B2 (en) * | 2005-04-25 | 2010-08-03 | Molly S Shoichet | Blends of temperature sensitive and anionic polymers for drug delivery |
WO2008134071A1 (en) * | 2007-04-26 | 2008-11-06 | Theraquest Biosciences, Inc. | Multimodal abuse resistant extended release formulations |
US8329744B2 (en) * | 2005-11-02 | 2012-12-11 | Relmada Therapeutics, Inc. | Methods of preventing the serotonin syndrome and compositions for use thereof |
US20100210732A1 (en) * | 2005-11-02 | 2010-08-19 | Najib Babul | Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor |
WO2007087452A2 (en) * | 2006-01-27 | 2007-08-02 | Theraquest Biosciences, Llc | Abuse resistant and extended release formulations and method of use thereof |
WO2007076358A1 (en) * | 2005-12-23 | 2007-07-05 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
FR2897775B1 (fr) * | 2006-02-24 | 2013-05-03 | Elisabeth Laugier | Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations |
US9119902B2 (en) * | 2006-06-22 | 2015-09-01 | Ethicon, Inc. | Semi-crystalline absorbable microspheres |
US8580307B2 (en) | 2006-06-22 | 2013-11-12 | Ethicon, Inc. | High glass transition temperature absorbable microspheres |
US8399619B2 (en) * | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
US20080004431A1 (en) * | 2006-06-30 | 2008-01-03 | Warsaw Orthopedic Inc | Method of manufacturing an injectable collagen material |
US8118779B2 (en) * | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
EP2068840A2 (en) * | 2006-07-21 | 2009-06-17 | LAB International SRL | Hydrophobic abuse deterrent delivery system |
US20080107744A1 (en) * | 2006-11-06 | 2008-05-08 | Jack Fa-De Chu | Injectable hollow tissue filler |
WO2008066382A1 (en) * | 2006-11-29 | 2008-06-05 | Cam Aesthetics B.V. I.O. | Carboxymethyl cellulose-stabilised tissue filler and its preparation and use |
US7776840B2 (en) * | 2007-02-21 | 2010-08-17 | Cutanea Life Sciences, Inc. | Methods of use of biomaterial and injectable implant containing biomaterial |
EP2162158A2 (en) * | 2007-05-23 | 2010-03-17 | Allergan, Inc. | Coated hyaluronic acid particles |
US20080293637A1 (en) * | 2007-05-23 | 2008-11-27 | Allergan, Inc. | Cross-linked collagen and uses thereof |
NZ582813A (en) | 2007-07-26 | 2011-09-30 | Aqtis Ip Bv | Microparticles comprising pcl and uses thereof |
US20110077737A1 (en) * | 2007-07-30 | 2011-03-31 | Allergan, Inc. | Tunably Crosslinked Polysaccharide Compositions |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US20090081173A1 (en) * | 2007-08-10 | 2009-03-26 | The Board Of Regents Of The University Of Texas System | Methods and compositions involving bacteriophage isolates |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
US8475815B2 (en) | 2007-10-29 | 2013-07-02 | Ayman Boutros | Alloplastic injectable dermal filler and methods of use thereof |
US7910134B2 (en) | 2007-10-29 | 2011-03-22 | Ayman Boutros | Alloplastic injectable dermal filler and methods of use thereof |
US8709395B2 (en) | 2007-10-29 | 2014-04-29 | Ayman Boutros | Method for repairing or replacing damaged tissue |
US8431141B2 (en) * | 2007-10-29 | 2013-04-30 | Ayman Boutros | Alloplastic injectable dermal filler and methods of use thereof |
SI2818184T1 (sl) | 2007-11-16 | 2019-03-29 | Aclaris Therapeutics, Inc. | Sestava in postopki za zdravljenje purpure |
US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
WO2009079555A2 (en) * | 2007-12-17 | 2009-06-25 | Anna Love | Soft tissue filler |
US20090198331A1 (en) * | 2008-02-01 | 2009-08-06 | Kesten Randy J | Implantable prosthesis with open cell flow regulation |
US20090198329A1 (en) | 2008-02-01 | 2009-08-06 | Kesten Randy J | Breast implant with internal flow dampening |
US8678008B2 (en) * | 2008-07-30 | 2014-03-25 | Ethicon, Inc | Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea |
US8556797B2 (en) * | 2008-07-31 | 2013-10-15 | Ethicon, Inc. | Magnetic implants for treating obstructive sleep apnea and methods therefor |
US8357795B2 (en) | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
US8413661B2 (en) | 2008-08-14 | 2013-04-09 | Ethicon, Inc. | Methods and devices for treatment of obstructive sleep apnea |
AU2009288118B2 (en) | 2008-09-02 | 2014-12-11 | Allergan, Inc. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US20100080791A1 (en) * | 2008-09-26 | 2010-04-01 | Rousseau Robert A | Composition and Method For Treating Tissue Defects |
US8561616B2 (en) | 2008-10-24 | 2013-10-22 | Ethicon, Inc. | Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea |
US8561617B2 (en) | 2008-10-30 | 2013-10-22 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8800567B2 (en) | 2008-12-01 | 2014-08-12 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8783258B2 (en) | 2008-12-01 | 2014-07-22 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8371308B2 (en) | 2009-02-17 | 2013-02-12 | Ethicon, Inc. | Magnetic implants and methods for treating an oropharyngeal condition |
US8307831B2 (en) | 2009-03-16 | 2012-11-13 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US10105197B1 (en) | 2009-03-26 | 2018-10-23 | Fernando Colon | Method of treatment for periodontal pockets |
US9200112B2 (en) | 2009-08-10 | 2015-12-01 | Ethicon, Inc. | Semi-crystalline, fast absorbing polymer formulation |
US9326886B2 (en) | 2009-10-29 | 2016-05-03 | Ethicon, Inc. | Fluid filled implants for treating obstructive sleep apnea |
US9877862B2 (en) * | 2009-10-29 | 2018-01-30 | Ethicon, Inc. | Tongue suspension system with hyoid-extender for treating obstructive sleep apnea |
US9974683B2 (en) * | 2009-10-30 | 2018-05-22 | Ethicon, Inc. | Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea |
US9044524B2 (en) * | 2009-10-30 | 2015-06-02 | Ethicon, Inc. | Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants |
US8632488B2 (en) | 2009-12-15 | 2014-01-21 | Ethicon, Inc. | Fluid filled implants for treating medical conditions |
US8980248B2 (en) | 2009-12-18 | 2015-03-17 | The Governing Council Of The University Of Toronto | Injectable polymer composition for use as a cell delivery vehicle |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
EP2544652A2 (en) | 2010-03-12 | 2013-01-16 | Allergan Industrie SAS | A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition. |
HUE043344T2 (hu) | 2010-03-22 | 2019-08-28 | Allergan Inc | Térhálósított hidrogélek lágy szövet növelésére |
US8815228B2 (en) | 2010-04-30 | 2014-08-26 | Ayman Boutros | Alloplastic injectable dermal filler and methods of use thereof |
KR101003331B1 (ko) | 2010-05-11 | 2010-12-23 | 조강선 | 피부 충전제 조성물 |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
RU2624239C2 (ru) | 2011-06-03 | 2017-07-03 | Аллерган, Инк. | Составы кожного наполнителя, включая антиоксиданты |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
US8905033B2 (en) | 2011-09-28 | 2014-12-09 | Ethicon, Inc. | Modular tissue securement systems |
US9161855B2 (en) | 2011-10-24 | 2015-10-20 | Ethicon, Inc. | Tissue supporting device and method |
US8973582B2 (en) | 2011-11-30 | 2015-03-10 | Ethicon, Inc. | Tongue suspension device and method |
US10470760B2 (en) | 2011-12-08 | 2019-11-12 | Ethicon, Inc. | Modified tissue securement fibers |
US9173766B2 (en) | 2012-06-01 | 2015-11-03 | Ethicon, Inc. | Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients |
ES2761558T3 (es) | 2014-09-30 | 2020-05-20 | Allergan Ind Sas | Composiciones de hidrogel estables que incluyen aditivos |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
SI3397651T1 (sl) | 2015-12-29 | 2020-11-30 | Galderma S.A. | Oglikovodično zamreževalo |
CN105664261B (zh) * | 2016-02-18 | 2018-09-21 | 江苏西宏生物医药有限公司 | 一种注射植入剂的制备方法 |
CN105727370B (zh) * | 2016-02-18 | 2018-11-06 | 江苏西宏生物医药有限公司 | 一种注射植入剂 |
RU2641053C1 (ru) * | 2016-09-21 | 2018-01-15 | Наталья Павловна Михайлова | Твёрдофазный способ получения биоактивного композита для наращивания ткани на основе гиалуроновой кислоты и микрочастиц полилактида или его сополимеров и способ получения имплантата на основе этого композита |
US10821200B2 (en) * | 2016-12-05 | 2020-11-03 | Hyalo Technologies, LLC | Method of sterilization of microparticles |
CN108619563A (zh) * | 2017-03-18 | 2018-10-09 | 浙江臻我生物技术有限公司 | 一种聚乳酸组合物及其制备方法 |
CN108619564A (zh) * | 2017-03-18 | 2018-10-09 | 浙江臻我生物技术有限公司 | 一种用于皮肤填充的组合物及其制备方法 |
US11331411B2 (en) | 2017-05-30 | 2022-05-17 | Aqpha Ip B.V. | Resorbable biodegradable medical and cosmetic composition comprising poly(1,3-trimethylene carbonate) |
WO2020129028A1 (en) * | 2018-12-21 | 2020-06-25 | Nestlé Skin Health S.A. | Hydrogel compositions encapsulating solid particles |
US20200376128A1 (en) | 2019-06-01 | 2020-12-03 | Lupin Holdings B.V. | Monodisperse resorbable polyester polymer compositions, systems, and methods |
CN110339397B (zh) * | 2019-07-11 | 2021-12-21 | 山东省药学科学院 | 一种不含助悬剂的可注射皮肤填充剂及其制备方法和用途 |
CN110327497A (zh) * | 2019-07-31 | 2019-10-15 | 易浦润(上海)生物技术有限公司 | 一种含微球的注射用凝胶及其制备方法 |
US11235087B2 (en) | 2019-10-28 | 2022-02-01 | Galderma Holding SA | Ready-to-use esthetic compositions |
CA3160575A1 (en) | 2019-12-02 | 2021-06-10 | Johan Olsson | High molecular weight esthetic compositions |
CN113058074B (zh) * | 2020-01-02 | 2022-04-29 | 华利源(上海)生物医药科技有限公司 | 温敏填充剂组合物 |
CN113117143B (zh) * | 2020-01-14 | 2023-11-28 | 渼颜空间(河北)生物科技有限公司 | 透明质酸用于制备可生物降解的聚合物微粒制剂的应用 |
CN111150883A (zh) * | 2020-01-14 | 2020-05-15 | 北京四环制药有限公司 | 可生物降解的注射填充物及其制备方法和其应用 |
CN114099771A (zh) * | 2020-08-27 | 2022-03-01 | 杭州协合医疗用品有限公司 | 一种含混合聚合物微球的梯度注射剂 |
KR102266384B1 (ko) * | 2021-01-25 | 2021-06-21 | 주식회사 울트라브이 | 필러용 생분해성 고분자 미세입자, 이를 포함한 필러용 동결건조체, 그 제조방법 및 상기 동결건조체를 포함하는 필러용 주사제 |
CN113877000B (zh) * | 2021-10-13 | 2023-01-24 | 科笛生物医药(无锡)有限公司 | 注射用微球组合物及其应用 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2185152A (en) * | 1939-12-26 | Diazo derivatives of gtjanidyl | ||
US2756867A (en) * | 1950-11-21 | 1956-07-31 | Joy Mfg Co | Conveyor chain with replaceable flights |
US2758987A (en) | 1952-06-05 | 1956-08-14 | Du Pont | Optically active homopolymers containing but one antipodal species of an alpha-monohydroxy monocarboxylic acid |
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
CH530951A (de) * | 1970-08-04 | 1972-11-30 | Ciba Geigy Ag | Verfahren zur Herstellung von 2,3-disubstituierten 1,3-Butadienen |
CH611150A5 (ko) * | 1975-04-18 | 1979-05-31 | Sulzer Ag | |
US4166800A (en) | 1977-08-25 | 1979-09-04 | Sandoz, Inc. | Processes for preparation of microspheres |
US4919929A (en) | 1984-02-01 | 1990-04-24 | Stolle Research & Development Corporation | Mammal immunization |
CA1196864A (en) | 1983-06-10 | 1985-11-19 | Mattheus F.A. Goosen | Controlled release of injectable and implantable insulin compositions |
US5061281A (en) | 1985-12-17 | 1991-10-29 | Allied-Signal Inc. | Bioresorbable polymers and implantation devices thereof |
EP0226061B1 (en) | 1985-12-17 | 1994-02-16 | United States Surgical Corporation | High molecular weight bioresorbable polymers and implantation devices thereof |
US4780320A (en) | 1986-04-29 | 1988-10-25 | Pharmetrix Corp. | Controlled release drug delivery system for the periodontal pocket |
US4803075A (en) * | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
JPS63122620A (ja) * | 1986-11-12 | 1988-05-26 | Sanraku Inc | ポリ乳酸マイクロスフエア及びその製造方法 |
FR2618674B1 (fr) | 1987-07-30 | 1990-06-15 | Ire Celltarg Sa | Microparticules comportant un polymere biodegradable controlant la liberation d'un principe actif antimalarique, compositions pharmaceutiques en comprenant et procede de preparation |
US4969912A (en) * | 1988-02-18 | 1990-11-13 | Kelman Charles D | Human collagen processing and autoimplant use |
JP2670680B2 (ja) * | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
US4897287A (en) | 1988-10-06 | 1990-01-30 | The Boc Group, Inc. | Metallization process for an integrated circuit |
DE3841401A1 (de) | 1988-12-08 | 1990-06-13 | Martin Lemperle | Alloplastisches implantat |
US5258028A (en) * | 1988-12-12 | 1993-11-02 | Ersek Robert A | Textured micro implants |
US5185152A (en) | 1990-01-10 | 1993-02-09 | Peyman Gholam A | Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye |
US5059123A (en) | 1990-05-14 | 1991-10-22 | Jernberg Gary R | Periodontal barrier and method for aiding periodontal tissue regeneration |
US5288496A (en) | 1990-05-15 | 1994-02-22 | Stolle Research & Development Corporation | Growth promoters for animals |
MX9203083A (es) * | 1991-06-21 | 1994-08-31 | Genetics Inst | Formulaciones farmaceuticas de proteinas osteogenicas. |
US5356629A (en) * | 1991-07-12 | 1994-10-18 | United States Surgical Corporation | Composition for effecting bone repair |
JPH05194189A (ja) | 1991-10-23 | 1993-08-03 | Boehringer Ingelheim Kg | 乳酸に基づくオリゴマー及び/又はポリマーの半固形混合物、それらの製造方法並びに吸収性埋め込み物としてのそれらの使用 |
DE4235312A1 (de) | 1991-10-23 | 1993-04-29 | Boehringer Ingelheim Kg | Halbfeste mischungen aus oligomeren und/oder polymeren auf der basis von milchsaeure, verfahren zu deren herstellung und deren verwendung als resorbierbare implantate |
FR2686250A1 (fr) * | 1992-01-16 | 1993-07-23 | Coletica | Compositions injectables contenant en suspension des microcapsules a base de collagene, leur utilisation biomedicale et des compositions pharmaceutiques. |
US5470582A (en) | 1992-02-07 | 1995-11-28 | Syntex (U.S.A.) Inc. | Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles |
ZA93506B (en) * | 1992-02-11 | 1994-05-11 | Bristol Myers Squibb Co | Soft tissue augmentation material |
US5204382A (en) | 1992-02-28 | 1993-04-20 | Collagen Corporation | Injectable ceramic compositions and methods for their preparation and use |
GB9206509D0 (en) * | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
SE509991C2 (sv) | 1992-07-20 | 1999-03-29 | Bengt Hjalmar Aagerup Med Firm | Biologiskt nedbrytbar vävnadsförstärkning |
ZA938595B (en) * | 1992-12-23 | 1994-08-05 | Ndm Acquisition Corp | Wound dressing having a cylindrical shape for deep wounds. |
JP2995090B2 (ja) | 1993-03-19 | 1999-12-27 | キユー・メド・アクチエボラーグ | 組織増大のための組成物および方法 |
US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
JPH07125508A (ja) | 1993-09-09 | 1995-05-16 | Bridgestone Corp | 空気入りタイヤ |
GB2281861B (en) * | 1993-09-21 | 1997-08-20 | Johnson & Johnson Medical | Bioabsorbable wound implant materials containing microspheres |
JPH07265421A (ja) | 1994-03-28 | 1995-10-17 | Shibuya Kogyo Co Ltd | ダブルチャンバーシリンジの製造方法 |
US5478837A (en) | 1994-06-07 | 1995-12-26 | University Of Southern California | Use of quinacrine in preventing adhesion formation |
US5451406A (en) * | 1994-07-14 | 1995-09-19 | Advanced Uroscience, Inc. | Tissue injectable composition and method of use |
AU706434B2 (en) * | 1994-10-18 | 1999-06-17 | Ethicon Inc. | Injectable liquid copolymers for soft tissue repair and augmentation |
US5599852A (en) * | 1994-10-18 | 1997-02-04 | Ethicon, Inc. | Injectable microdispersions for soft tissue repair and augmentation |
FR2733426B1 (fr) * | 1995-04-25 | 1997-07-18 | Debacker Yves | Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique |
US6287341B1 (en) * | 1995-05-19 | 2001-09-11 | Etex Corporation | Orthopedic and dental ceramic implants |
US5977204A (en) * | 1997-04-11 | 1999-11-02 | Osteobiologics, Inc. | Biodegradable implant material comprising bioactive ceramic |
FR2764514B1 (fr) * | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
US5837752A (en) * | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
AU9313298A (en) * | 1997-09-04 | 1999-03-22 | Point Biomedical Corporation | Injectable tissue reconstruction material |
WO1999058082A2 (en) | 1998-05-14 | 1999-11-18 | The Cleveland Clinic Foundation | Processing of implantable animal tissues for dry storage |
FR2778847A1 (fr) * | 1998-05-20 | 1999-11-26 | Jean Pierre Perraud | Implant injectable en sous gingival resorbable, constitue de microspheres a liberation prolongee et chargees en principes actifs et en suspension dans un gel vecteur |
EP1303236B1 (en) * | 2000-07-14 | 2008-12-03 | Kyphon SARL | Systems for treating vertebral bodies |
-
1997
- 1997-06-13 FR FR9707334A patent/FR2764514B1/fr not_active Expired - Fee Related
-
1998
- 1998-06-12 WO PCT/FR1998/001241 patent/WO1998056431A1/fr active IP Right Grant
- 1998-06-12 KR KR1019997001267A patent/KR100543560B1/ko not_active IP Right Cessation
- 1998-06-12 PT PT98932196T patent/PT969883E/pt unknown
- 1998-06-12 DK DK98932196T patent/DK0969883T3/da active
- 1998-06-12 RO RO99-00141A patent/RO118261B1/ro unknown
- 1998-06-12 PL PL98331703A patent/PL331703A1/xx unknown
- 1998-06-12 ES ES98932196T patent/ES2210776T3/es not_active Expired - Lifetime
- 1998-06-12 US US09/242,103 patent/US6716251B1/en not_active Expired - Lifetime
- 1998-06-12 AU AU82182/98A patent/AU744366B2/en not_active Expired
- 1998-06-12 JP JP11501805A patent/JP2000516839A/ja active Pending
- 1998-06-12 TR TR1999/00297T patent/TR199900297T1/xx unknown
- 1998-06-12 EP EP98932196A patent/EP0969883B1/fr not_active Expired - Lifetime
- 1998-06-12 RU RU99105121/14A patent/RU2214283C2/ru active
- 1998-06-12 HU HU0001465A patent/HU228462B1/hu unknown
- 1998-06-12 IL IL12821098A patent/IL128210A/en not_active IP Right Cessation
- 1998-06-12 CA CA002263361A patent/CA2263361C/fr not_active Expired - Lifetime
- 1998-06-12 DE DE69819694T patent/DE69819694T2/de not_active Expired - Lifetime
- 1998-06-12 AT AT98932196T patent/ATE253947T1/de active
- 1998-06-12 BR BR9804962-3A patent/BR9804962A/pt not_active Application Discontinuation
-
2000
- 2000-07-04 HK HK00104039A patent/HK1025268A1/xx not_active IP Right Cessation
-
2004
- 2004-03-26 US US10/809,349 patent/US7731758B2/en not_active Expired - Lifetime
-
2010
- 2010-05-10 US US12/776,909 patent/US20100221684A1/en not_active Abandoned
-
2012
- 2012-05-21 US US13/476,390 patent/US8414657B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100759091B1 (ko) | 2006-12-13 | 2007-09-17 | 조강선 | 피부 충전제 조성물 |
KR101852127B1 (ko) | 2016-04-11 | 2018-04-25 | 주식회사 지씨에스 | 폴리엘락틱산 필러와 히알루론산 필러 결합체의 제조방법 |
WO2020184744A1 (ko) * | 2019-03-08 | 2020-09-17 | 주식회사 지씨에스 | 복합체의 제조 방법 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100543560B1 (ko) | 피하 또는 피부내 주사용 삽입물 | |
KR100954741B1 (ko) | 생분해성 주사가능한 이식제 및 관련된 제조방법과 용도 | |
US5945115A (en) | Polymeric compositions useful as controlled release implants | |
US5702716A (en) | Polymeric compositions useful as controlled release implants | |
AU2002315505A1 (en) | Biodegradable injectable implants and related methods of manufacture and use | |
Jain et al. | Biodegradable polymers in drug delivery | |
US20070190101A1 (en) | Flowable bone grafts | |
CN111558083B (zh) | 可生物降解的注射填充物及其制备方法和其应用 | |
CN111617315B (zh) | 可生物降解的注射填充物及其制备方法和其应用 | |
RU2315627C2 (ru) | Впрыскиваемые имплантаты на керамической основе для заполнения морщин, кожных впадин и шрамов и способ их получения | |
JPH07503001A (ja) | コラーゲンマイクロカプセル含有注射可能組成物 | |
CN113209370B (zh) | 可生物降解的注射填充物及其制备方法和其应用 | |
CN113117142B (zh) | 可生物降解的注射填充物及其制备方法和其应用 | |
CN113117143A (zh) | 透明质酸用于制备降低plla注射刺激性的组合物中的应用 | |
WO2020177830A1 (en) | Long lasting biodegradable polymer based in-situ forming implant for treatment of bone injuries | |
Darvari et al. | Controlled Release Antibiotics for Treatment of Periodontal Disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121226 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20131220 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141223 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20151217 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20161220 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 13 |
|
EXPY | Expiration of term |